News from ACCELERATE

29/01/2024

ACCELERATE 2024 Annual Conference

We are delighted to invite you to the upcoming 12th ACCELERATE Annual Conference, where innovation meets expertise in paediatric oncology drug development.

Exciting Speaker Updates: Prepare for an enriching experience as we unveil the latest additions to our speaker lineup. Check out the conference programme to discover more!

📅 8 & 9 February 2024

📍 Brussels & Online

 

Join us for the 13th Paediatric Strategy Forum for Diffuse Midline Gliomas

The 13th ACCELERATE Paediatric Strategy Forum Expression of Interest is open! Join us for this crucial discussion on the Medicinal Product Development of Diffuse Midline Gliomas.

This time, we're honored to be hosted by the Hospital for Sick Children (SickKids) in Toronto for this impactful event. Submit Expression of Interest Today

📅 8 & 9 May 2024

📍 SickKids, Toronto & Online

 

New ACCELERATE Articles

  1. Rescuing Drugs That are Discontinued in Adult Oncology Development for the Benefit of Children and Adolescents With Cancer – An ACCELERATE Multistakeholder Consensus
  2. Impact of ACCELERATE Paediatric Strategy Forums: A review of the value of multi-stakeholder meetings in oncology drug development

 

Introducing the ACCELERATE Working Group on Patient Reported Outcomes

Over 50 experts are geared up to join forces and pave the way for meaningful implementation of PROs in clinical trials.

Stay tuned for more information!